Desvenlafaxine Succinate is an antidepressant medication. It works by increasing levels of certain chemicals in the brain that help regulate mood. It is often used to treat depression.
Every report comes from a Lived member, sent anonymously.
Have you tried Pristiq (Desvenlafaxine) for Depression?
Desvenlafaxine, sold under the brand name Pristiq and also available as a generic, is a prescription antidepressant approved to treat major depressive disorder (clinical depression) in adults. It is not approved for children or teenagers. It belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). Desvenlafaxine is the main active substance the body makes from venlafaxine, an older SNRI, so the two are closely related. Antidepressants are one part of depression care, and talk therapy may be used alongside medication or instead of it, depending on how severe the depression is and what a person prefers.
Serotonin and norepinephrine are chemical messengers that brain cells use to communicate, and both are involved in mood, motivation and the body's response to stress. After carrying a signal, these messengers are normally pulled back into the nerve cell that released them. Desvenlafaxine slows that reabsorption for both, leaving more of them available between nerve cells. This chemical change happens soon after starting the medicine, but mood usually improves only over several weeks. Exactly why depression lifts is not fully understood, and the effect on brain chemistry is only part of the explanation.
Desvenlafaxine is taken once a day as an extended-release tablet, at about the same time each day, with or without food. The usual dose is 50 mg, which is both the starting and the treatment dose. In clinical trials, higher doses did not work better and caused more side effects. A 25 mg tablet is mainly used for tapering off the medicine and for people with severe kidney disease, and kidney or liver problems can lower the maximum dose a prescriber will use. The tablet is built to release the medicine slowly, so it must be swallowed whole with liquid, not split, crushed, chewed or dissolved. Some people notice what looks like a tablet in their stool. This is the empty shell, and the medicine has already been absorbed. Do not stop desvenlafaxine suddenly. Lowering the dose gradually with the prescriber's guidance reduces withdrawal effects, and some people need to taper over several months.
Nausea is the most common side effect, especially in the first weeks. Dizziness, trouble sleeping or sleepiness, heavy sweating, dry mouth, constipation and reduced appetite are also common. Many of these ease as the body adjusts. Sexual side effects, such as lower desire, delayed or absent orgasm, or erection or ejaculation problems, can persist and are worth raising with the prescriber rather than putting up with silently. Serotonin syndrome is a rare but potentially life-threatening reaction caused by too much serotonin activity, and the risk rises when desvenlafaxine is combined with other medicines that affect serotonin. Signs include agitation or confusion, a fast heartbeat, heavy sweating or fever, and muscle stiffness, twitching or tremor; these need emergency care. Rash, hives or swelling of the face should be reported to the prescriber right away. Swelling of the tongue or throat, trouble swallowing or trouble breathing is an emergency. Less often, SNRIs can lower blood sodium, mainly in older adults and people taking diuretics (water pills). Headache, confusion, weakness or unsteadiness are signs to report.
Like all antidepressants, desvenlafaxine carries a US Food and Drug Administration (FDA) boxed warning: in short-term studies, antidepressants increased suicidal thoughts and behaviors in children, teenagers and young adults under 25. People of any age should be watched closely for worsening depression, new suicidal thoughts, or unusual agitation or behavior changes, especially in the first few months and after any dose change, and these should be reported to the prescriber promptly. Family members can help by noticing such changes. Desvenlafaxine must not be combined with MAOIs (monoamine oxidase inhibitors, an older type of antidepressant). At least 14 days must pass after stopping an MAOI before starting desvenlafaxine, and 7 days after stopping desvenlafaxine before starting an MAOI. The same caution applies to the antibiotic linezolid and to methylene blue, a dye given by IV during some surgeries and also used to treat a rare blood disorder; both can trigger the same dangerous serotonin reaction, so anyone facing surgery or a hospital procedure should tell the team they take desvenlafaxine. Other medicines that raise serotonin, including other antidepressants, triptan migraine medicines, tramadol and other opioid pain medicines, lithium (a mood stabilizer used for bipolar disorder) and the herbal supplement St. John's wort, increase the risk of serotonin syndrome. It should not be taken with venlafaxine (Effexor XR) or another desvenlafaxine product. Desvenlafaxine can raise blood pressure, so high blood pressure should be controlled before starting and checked during treatment, with extra care for people with heart or blood vessel conditions that higher blood pressure could worsen. It can also increase bleeding risk, particularly with aspirin, anti-inflammatory pain relievers such as ibuprofen and naproxen, and blood thinners such as warfarin. People with untreated narrow-angle glaucoma, a personal or family history of bipolar disorder, or seizures need a careful discussion first, because an antidepressant can trigger an eye-pressure attack, mania or a seizure in these settings. Alcohol is best avoided. Anyone pregnant or planning pregnancy should talk with the prescriber rather than stopping on their own. Untreated depression carries its own risks, while SNRI use late in pregnancy is linked to bleeding after delivery and to problems in the newborn that sometimes need extra hospital care.
Sleep, energy or appetite may improve before mood does. Antidepressants usually take four to eight weeks to show their full effect, and side effects such as nausea often appear before the benefits. If the response is weak or side effects are hard to live with after a fair trial, the prescriber may suggest another medicine or approach rather than a higher dose, since doses above 50 mg have not shown extra benefit. Follow-up visits are used to check mood, side effects and blood pressure. After depression improves, treatment usually continues for several months or longer to lower the chance of it returning. When it is time to stop, the prescriber will plan a gradual taper. Withdrawal symptoms such as dizziness, nausea, irritability, anxiety and electric shock-like sensations can occur and are sometimes severe or long-lasting, so changes in mood during a taper should be reported.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Pristiq (Desvenlafaxine), what you've noticed, or ask the community a question.